Newly Approved Drug Therapies (566) Xenical/Orlistat Capsules, Roche,

The global source of news, directories, proprietary market research, and analysis for clinical trials professionals and patients.

Drug Info

Bookmark | Print | E-Mail

Receive E-mails About New Clinical Trials!

Sign up for our FREE service and we'll send you automatic e-mail notifications as soon as a clinical trial is posted in the medical category you're interested in.

Home » Drug Information » FDA-Approved Drugs » 1999
Medical Areas: Endocrinology

View By: Year Company Therapeutic Areas Drug Names

Drug Information

The following information is obtained from various newswires, published medical journal articles, and medical conference presentations.

Drug Name: Xenical/Orlistat Capsules

Company: Roche
Approval Status: Approved April 1999
Treatment Area: Endocrinology

General Information

Xenical/Orlistat Capsules, 120 mg, a lipase inhibitor, have been approved for obesity management. Xenical acts by inhibiting the absorption of dietary fats.

Privacy |
Glossary